Evidence map›Paper›PMID 33870451›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis.

Sena Genç Elden, Mahmut Sinan Yılmaz, Mustafa Altındiş, Mehmet Köroğlu, Halil Elden

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sena Genç EldenDepartment of Otorhinolaryngology, Hendek State Hospital, Çağlayan Mahallesi Dr. Cevdet Şahinli Caddesi No:30, 54300, Hendek/Sakarya, Turkey. ssenagenc@gmail.com.ORCID http://orcid.org/0000-0002-3479-1600
Mahmut Sinan YılmazDepartment of Otorhinolaryngology, Sakarya University Faculty of Medicine, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-5323-0059
Mustafa AltındişFaculty of Medicine, Department of Clinical Virology and Microbiology, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0003-0411-9669
Mehmet KöroğluFaculty of Medicine, Department of Clinical Virology and Microbiology, Sakarya University, Sakarya, Turkey.ORCID http://orcid.org/0000-0001-8101-1104
Halil EldenDepartment of Otorhinolaryngology, Sakarya University Faculty of Medicine, Sakarya, Turkey.ORCID http://orcid.org/0000-0002-6306-4357
Sakarya University · TRState Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to investigate the importance of atherosclerosis in the pathogenesis of sudden hearing loss by evaluating the newly discovered markers, serum salusin-α and salusin-β. We also aimed to evaluate atherosclerosis risk factors, such as lipid profile, smoking, body mass index, waist circumference and mean blood pressure of the patients.

methodsFifty-two patients diagnosed with sudden hearing loss (study group) and fifty healthy people (control group) were included in the study. Detailed history was taken from the patients and risk factors for atherosclerosis, such as smoking, body mass index, waist circumference, lipid profile, mean blood pressure and serum salusin-α and salusin-β levels, were evaluated. The study group was divided into recovery group (subgroup I) and non-recovery group (subgroup II).

resultsThe salusin-β median value was found to be significantly higher in the study group compared to the control group (p < 0.05). The salusin-β median value was found to be significantly higher in subgroup 2 and was found to be a poor prognostic factor (p < 0.05).

conclusionFrom the results obtained in this study, it is thought that salusin-β peptide is increased in patients with sudden hearing loss and it can be evaluated as a poor prognostic factor.

Indexed as

AtherosclerosisHearing Loss, SuddenBiomarkersHumansIntercellular Signaling Peptides and ProteinsRisk FactorsBiomarkersIntercellular Signaling Peptides and ProteinsAtherosclerosisPrognosisSalusin alphaSalusin betaSudden hearing loss

Identifiers

PMID33870451
OpenAlexW3153248871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.